The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 23, 2015
Filed:
Aug. 26, 2005
James E. Hitt, Midland, MI (US);
True L. Rogers, Midland, MI (US);
Ian B. Gillespie, Linden, MI (US);
Brian D. Scherzer, Midland, MI (US);
Paula C. Garcia, Midland, MI (US);
Nicholas S. Beck, Midland, MI (US);
Christopher J. Tucker, Midland, MI (US);
Timothy J. Young, Bay City, MI (US);
David A. Hayes, Midland, MI (US);
Robert O. Williams, Iii, Austin, TX (US);
Keith P. Johnston, Austin, TX (US);
Jason T. Mcconville, Austin, TX (US);
Jay I. Peters, San Antonio, TX (US);
Robert Talbert, San Antonio, TX (US);
David Burgess, San Antonio, TX (US);
James E. Hitt, Midland, MI (US);
True L. Rogers, Midland, MI (US);
Ian B. Gillespie, Linden, MI (US);
Brian D. Scherzer, Midland, MI (US);
Paula C. Garcia, Midland, MI (US);
Nicholas S. Beck, Midland, MI (US);
Christopher J. Tucker, Midland, MI (US);
Timothy J. Young, Bay City, MI (US);
David A. Hayes, Midland, MI (US);
Robert O. Williams, III, Austin, TX (US);
Keith P. Johnston, Austin, TX (US);
Jason T. McConville, Austin, TX (US);
Jay I. Peters, San Antonio, TX (US);
Robert Talbert, San Antonio, TX (US);
David Burgess, San Antonio, TX (US);
Board of Regents, the University of Texas System, Austin, TX (US);
Abstract
Inhalable compositions are described. The inhalable compositions comprise one or more respirable aggregates, the respirable aggregates comprising one or more poorly water soluble active agents, wherein at least one of the active agents reaches a maximum lung concentration (C) of at least about 0.25 μg/gram of lung tissue and remains at such concentration for a period of at least one hour after being delivered to the lung. Methods for making such compositions and methods for using such compositions are also disclosed.